Publications by authors named "David Belada"

52Publications

Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.

Eur J Clin Invest 2020 Oct 6:e13421. Epub 2020 Oct 6.

4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.

View Article and Find Full Text PDF
October 2020

Emergence of a lymphoma imitating an infectious infiltration surrounding the infrarenal aorta after EVAR.

Vasa 2019 Nov 4;48(6):531-534. Epub 2019 Jul 4.

4th Department of Internal Medicine - Haematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.

View Article and Find Full Text PDF
November 2019

Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.

Orphanet J Rare Dis 2019 01 9;14(1). Epub 2019 Jan 9.

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.

View Article and Find Full Text PDF
January 2019

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry.

Leuk Lymphoma 2019 03 6;60(3):748-755. Epub 2018 Sep 6.

b 1st Department of Internal Medicine - Department of Hematology , First Faculty of Medicine and General Teaching Hospital , Prague , Czech Republic.

View Article and Find Full Text PDF
March 2019

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2017 Nov 10;35(31):3529-3537. Epub 2017 Aug 10.

Umberto Vitolo, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin; Angelo Michele Carella, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera e Universitaria San Martino-IST, Genoa; Antonio Pinto, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples; Maurizio Martelli, Sapienza University, Rome, Italy; Marek Trněný, Charles University, General Hospital, Prague; David Belada, Charles University Hospital, Hradec Králové, Czech Republic; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; US Oncology Research, The Woodlands, TX; Neil Chua, Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Laurie H. Sehn, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Pau Abrisqueta, University Hospital Vall d'Hebron, Barcelona, Spain; Judit Demeter, Semmelweiss University, Budapest, Hungary; Ian Flinn, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Xiaonan Hong, Fudan University Shanghai Cancer Center, Shanghai; Yuan-Kai Shi, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China; Won Seog Kim, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Republic of Korea; Yoichi Tatsumi, Kinki University Hospital, Osaka, Japan; Mikkel Z. Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger, Genentech, South San Francisco, CA.

View Article and Find Full Text PDF
November 2017

Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.

Arch Med Sci 2016 Apr 8;12(2):421-7. Epub 2015 Dec 8.

4 Department of Internal Medicine - Hematology, University Hospital and Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic.

View Article and Find Full Text PDF
April 2016

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.

Leuk Lymphoma 2016 12 18;57(12):2777-2783. Epub 2016 Apr 18.

b First Medical Department - Clinical Department of Haemato-oncology , First Faculty of Medicine and General Teaching Hospital, Charles University in Prague , Czech Republic.

View Article and Find Full Text PDF
December 2016

Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study.

Lancet Haematol 2015 Apr 25;2(4):e166-74. Epub 2015 Mar 25.

Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia. Electronic address:

View Article and Find Full Text PDF
April 2015

NK/T-cell lymphoma nasal type with an unusual clinical course.

Indian J Dermatol Venereol Leprol 2014 Nov-Dec;80(6):564-6

Department of Dentistry, Faculty of Medicine, University Hospital in Hradec Králové, Charles University in, Czech Republic.

View Article and Find Full Text PDF
May 2016

The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma.

Br J Haematol 2015 Apr 14;169(1):145-8. Epub 2014 Oct 14.

Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, University Hospital Motol, Charles University in Prague, Prague, Czech Republic.

View Article and Find Full Text PDF
April 2015

Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.

Leuk Res 2012 Oct 25;36(10):1278-82. Epub 2012 Jul 25.

2nd Department of Medicine, Department of Hematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.

View Article and Find Full Text PDF
October 2012

Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma.

Leuk Lymphoma 2011 Sep 23;52(9):1668-74. Epub 2011 Jun 23.

Department of Clinical Hematology, Charles University Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article and Find Full Text PDF
September 2011

Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.

Int J Dermatol 2009 Dec;48(12):1338-42

2nd Department of Internal Medicine, Teaching Hospital, Hradec Králové, Czech Republic.

View Article and Find Full Text PDF
December 2009

Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma--a single-center, retrospective study.

Acta Medica (Hradec Kralove) 2007 ;50(2):113-8

2nd Department of Medicine, Division of Clinical Hematology, Charles University in Prague, Faculty of Medicine, University Hospital in Hradec Králové, Czech Republic.

View Article and Find Full Text PDF
February 2008

Optimization of the therapeutic procedure during LDL-apheresis--a computerized model.

Transfus Apher Sci 2005 Apr;32(2):149-56

Medical Faculty, Department of Haematology, Teaching Hospital, Charles University, Sokolska Street 408, 50005 Hradec Kralove, Czech Republic.

View Article and Find Full Text PDF
April 2005

Intravascular large B-cell lymphoma presenting as cutaneous panniculitis.

Acta Medica (Hradec Kralove) 2003 ;46(3):121-3

Fingerland Department of Pathology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic.

View Article and Find Full Text PDF
January 2004